Correlation Between Viridian Therapeutics and Flowtech Fluidpower

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Flowtech Fluidpower at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Flowtech Fluidpower into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Flowtech Fluidpower plc, you can compare the effects of market volatilities on Viridian Therapeutics and Flowtech Fluidpower and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Flowtech Fluidpower. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Flowtech Fluidpower.

Diversification Opportunities for Viridian Therapeutics and Flowtech Fluidpower

-0.1

Correlation Coefficient

Viridian Therapeutics  Flowtech Fluidpower

Good diversification

The 3 months correlation between Viridian and Flowtech is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Flowtech Fluidpower plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flowtech Fluidpower plc and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Flowtech Fluidpower. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flowtech Fluidpower plc has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Flowtech Fluidpower go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Flowtech Fluidpower

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.3 times more return on investment than Flowtech Fluidpower. However, Viridian Therapeutics is 1.3 times more volatile than Flowtech Fluidpower plc. It trades about -0.03 of its potential returns per unit of risk. Flowtech Fluidpower plc is currently generating about -0.14 per unit of risk. If you would invest  2,174  in Viridian Therapeutics on September 13, 2024 and sell it today you would lose (256.00) from holding Viridian Therapeutics or give up 11.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  Flowtech Fluidpower plc

Viridian Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Flowtech Fluidpower plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Flowtech Fluidpower plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Viridian Therapeutics and Flowtech Fluidpower

The main advantage of trading using opposite Viridian Therapeutics and Flowtech Fluidpower positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Flowtech Fluidpower can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flowtech Fluidpower will offset losses from the drop in Flowtech Fluidpower's long position.

The idea behind Viridian Therapeutics and Flowtech Fluidpower plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.